Follow the Pundits

Tag: Madrigal Pharmaceuticals

Golden fortress in a rugged mountain landscape with glowing DNA strands and a lone investor silhouette, symbolizing John Paulson’s high-conviction bets on gold and biotech

🏔️ John Paulson 2025: From "Short of the Century" to the "Long of the Decade"

John Paulson is back. After years under the radar, the legendary investor posted a 58% return in 2025—driven by high-conviction bets in biotech, gold, and strategic minerals. This is not diversification. This is precision investing.

Read entire article

Tags: 13f analysis, event driven investing, EventDrivenInvesting, featured-hedge-funds, funanc1al, gold stocks, GoldInvesting, hedge funds, high conviction investing, hub-hedge, john paulson, JohnPaulson, macro investing, madrigal pharmaceuticals, MDGL, mining stocks, MiningStocks, PaulsonAndCo, perpetua resources, portfolio strategy, stock market insights, StockMarket2026, THM
A glowing gold bar with rising stock charts and biotech symbols, representing John Paulson’s concentrated investment strategy in gold and healthcare.

John Paulson’s $5,000 Gold Bet: Genius or Gamble? 🚀

A hyper-concentrated portfolio, a $5,000 gold target, and massive biotech bets—John Paulson is back with one of the boldest strategies in markets today.

Read entire article

Tags: 13F Filings, Bausch Health, Biotech Stocks, Biotech Stocks 2026, featured-hedge-funds, FUNanc1al stocks, gold investing, gold miners, hedge funds, high conviction investing, hub-hedge, John Paulson, macro investing, Madrigal Pharmaceuticals, Perpetua Resources, portfolio analysis
Editorial illustration of scientist-investors analyzing biotech data with glowing tickers MDGL, BGNE, and INCY, representing Baker Bros’ science-driven investing strategy.

Madrigal, BeiGene, and Biotech Alpha: Inside the “Gene-ius” Kingmakers of Baker Bros. 2025

Biotech Jedi at work. Baker Bros’ 2025 victory lap shows how Madrigal, BeiGene, and ruthless conviction turned science into serious alpha.

Read entire article

Tags: ACAD, Acadia Pharma, Alkermes, ALKS, Baker Bros, Baker Bros Advisors, BeiGene, best hedge funds, BGNE, Biotech Investing, Concentrated Portfolios, featured-hedge-funds, FUNanc1al Edge, FUNanc1al Humor, FUNanc1al Investing, FunFund Index, Healthcare Innovation, Hedge Funds, hub-hedge, INCY, Incyte, INSM, Insmed, Long-Term Investing, Madrigal Pharmaceuticals, Market Leaders, MDGL, Revolution Medicines, RVMD